AXT, Inc. 2016 Q3 Form 10-Q Summary
Business Context and Reporting Period
AXT develops and manufactures compound and single-element semiconductor substrates, including indium phosphide, gallium arsenide and germanium wafers, and sells related raw materials. All manufacturing operations are in China, supported by partially owned Chinese subsidiaries and joint ventures. The filing covers the quarter and nine months ended September 30, 2016; financial statements are unaudited.
Key Financial Metrics
| Metric | Q3 2016 | Q3 2015 | 9M 2016 | 9M 2015 |
|---|---|---|---|---|
| Revenue | $21.9 million | $18.4 million | $61.1 million | $59.4 million |
| Gross profit | $7.6 million | $4.6 million | $18.9 million | $13.7 million |
| Gross margin | 34.6% | 25.1% | 30.9% | 23.1% |
| Operating income | $2.7 million | $(0.7) million | $4.1 million | $(3.2) million |
| Net income | $2.2 million | $0.05 million | $2.9 million | $(0.7) million |
| Net income attributable to AXT | $2.2 million | $0.04 million | $3.4 million | $(1.0) million |
| Diluted EPS | $0.07 | $(0.00) | $0.10 | $(0.03) |
- Q3 revenue increased 19.1% year over year; nine-month revenue increased 2.8%.
- Gross profit increased 64.6% in Q3 and 37.3% for the first nine months. Management attributed the margin expansion to product mix, improved yields, manufacturing efficiencies and higher production volume.
- Operating expenses were $4.9 million in Q3 and $14.8 million for nine months. Nine-month selling, general and administrative expense declined 20.3%, primarily because 2015 included professional fees related to a related-party investigation.
- Equity losses from unconsolidated joint ventures were $0.6 million in Q3 and $1.4 million for nine months, compared with equity earnings of $0.2 million and $0.8 million, respectively, in the prior-year periods.
- Other income declined to $0.2 million in Q3 and $0.7 million for nine months, partly because of lower realized investment gains, foreign-exchange gains and government subsidies.
Cash Flow, Liquidity and Capital Structure
- Operating cash flow was $5.5 million for the nine months ended September 30, 2016, compared with $2.3 million in the prior-year period.
- Cash and cash equivalents increased to $29.7 million from $24.9 million at December 31, 2015. Total cash, cash equivalents and investments were $47.3 million at September 30, 2016.
- Capital expenditures were $2.2 million for the nine months, compared with $3.5 million in 2015.
- The filing does not disclose conventional borrowings or senior debt. Total liabilities were $13.3 million, including $1.3 million of remaining royalty obligations and $0.4 million of operating lease obligations.
- Management stated that available cash and investments were adequate to meet expected needs over the next 12 months. Approximately $19.8 million of cash and investments were held in foreign bank accounts, of which approximately $12.6 million would not be available for U.S. use without potential U.S. tax consequences.
- No shares were repurchased during the first nine months of 2016; approximately $2.7 million remained available under the repurchase program.
Material Changes Versus the Prior Comparable Period
- Profitability improved materially, with the Company moving from an operating loss and net loss in the first nine months of 2015 to operating and net income in 2016.
- Revenue growth was concentrated in the third quarter. Nine-month growth remained modest because lower raw-material sales offset stronger substrate sales.
- Q3 regional revenue increased in Europe, China, Japan, Asia-Pacific excluding China, Taiwan and North America except Taiwan, where revenue declined 27.5% because of customer inventory adjustments. For nine months, revenue declined in Europe and North America but increased in China, Taiwan and Japan.
- The Company recorded a $226,000 restructuring charge in the second quarter of 2016 related to the elimination of 28 positions at Beijing JiYa; no additional charge was recorded in Q3.
- Nonconsolidated investment entities reported substantially weaker results, with aggregate net losses of $5.8 million for the first nine months of 2016 versus net income of $3.5 million in the prior-year period.
Guidance, Outlook, Risks and Unusual Items
- No specific numerical revenue or earnings guidance is provided in the filing. Management expects adequate liquidity for the next 12 months.
- Beijing authorities have pressured manufacturers in the Company’s area to relocate. A final central-government master plan and relocation timeline had not been determined. Management expects that gallium arsenide and germanium operations will eventually move, while indium phosphide production may remain at the current site.
- Relocation could require significant cash expenditures and could disrupt production, revenue and margins if not executed effectively. Management stated that the amount and timing of relocation costs could not be estimated.
- Raw-material businesses face declining selling prices and oversupply, particularly for gallium and germanium. These conditions contributed to losses at unconsolidated investments and could pressure future margins.
- Key risks include semiconductor industry cyclicality, declining average selling prices, customer concentration, product quality and yield issues, reliance on Chinese manufacturing and suppliers, foreign-exchange volatility, environmental and hazardous-material regulations, and potential restrictions affecting the gallium arsenide production permit.
- The Company has significant international exposure and uses short-term Japanese yen hedges, but hedging is partial and may not fully offset currency movements.
- The filing reports no material legal proceedings expected to adversely affect the Company and no off-balance-sheet financing arrangements.
- Management concluded that disclosure controls and procedures were effective as of September 30, 2016, with no material change in internal control over financial reporting during the nine months.
Investor Verification Checklist
- Verify whether the strong Q3 revenue and 34.6% gross margin were sustained in subsequent quarters or reflected temporary product mix and utilization benefits.
- Monitor the Beijing relocation plan, required permits, expected capital spending and any production or customer disruption.
- Assess exposure to declining gallium and germanium prices, inventory reserves and potential future write-downs.
- Review the performance and carrying values of unconsolidated Chinese investments, which generated significant losses in 2016.
- Evaluate geographic and customer concentration, including the concentration of sales and receivables among major customers.
- Confirm the availability and repatriation constraints of foreign-held cash and the potential cash requirement for relocation.
- Review future effects of the identified accounting standards, particularly revenue recognition, leases, equity investments and share-based compensation.